Cargando…

Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review

BACKGROUND AND OBJECTIVE: The fourth dose the COVID-19 vaccine was first proposed to immunocompromised patients. The aim of the article is to systematically review the literature and report the humoral response and outcomes after the fourth dose administration in people with impaired immune system....

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinelli, Silvia, Pascucci, Domenico, Laurenti, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076800/ https://www.ncbi.nlm.nih.gov/pubmed/37033069 http://dx.doi.org/10.3389/fpubh.2023.1108546

Ejemplares similares

Queueing Theory and COVID-19 Prevention: Model Proposal to Maximize Safety and Performance of Vaccination Sites
por: Di Pumpo, Marcello, et al.
Publicado: (2022)

Knowledge and beliefs about vaccination in pregnant women before and during the COVID-19 pandemic
por: Bruno, Stefania, et al.
Publicado: (2022)

A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain
por: Wang, Ji, et al.
Publicado: (2022)

The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons – Results of a Multicenter Observational Study
por: Heesen, Gloria, et al.
Publicado: (2022)

Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection
por: Schiffner, Julia, et al.
Publicado: (2021)

Prioritizing the First Doses of SARS-CoV-2 Vaccine to Save the Elderly: The Case Study of Italy
por: Pontrelli, Giuseppe, et al.
Publicado: (2021)

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
por: Díaz-Dinamarca, Diego A., et al.
Publicado: (2023)

Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
por: Oyaert, Matthijs, et al.
Publicado: (2022)

Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose
por: Mangia, Alessandra, et al.
Publicado: (2022)

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
por: Rescigno, Maria, et al.
Publicado: (2023)

(347) Augmented Humoral Response to a Third And Fourth Dose of Mrna Sars-Cov-2 Vaccines in Lung Transplant Recipients
por: Kawana, S., et al.
Publicado: (2023)

Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
por: Han, Shanshan, et al.
Publicado: (2023)

Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
por: Meredith, Rhys T., et al.
Publicado: (2023)

Durability of Humoral Immune Responses to SARS-CoV-2 in Citizens of Ariano Irpino (Campania, Italy): A Longitudinal Observational Study With an 11.5-Month Follow-Up
por: Coppola, Annachiara, et al.
Publicado: (2021)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
por: Srivastava, Utkarsh, et al.
Publicado: (2022)

Humor and Fear—Two Sides of the Same Coin?: Experimental Evidence on Humor Appeals in Health Communication Related to Childhood Vaccination
por: Fischer, Florian, et al.
Publicado: (2021)

Movement restrictions, vaccine coverage, and reduction of the COVID-19 incidence rate in the fourth wave of the pandemic: Analysis results from 63 provinces in Vietnam
por: Bui, Hanh My, et al.
Publicado: (2023)

Anti-SARS-CoV-2 spike IgG following injection of the third dose vaccine: A systematic review with meta-analysis of heterologous versus homologous vaccination
por: Mojadadi, Mohammad-Shafi, et al.
Publicado: (2023)

How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants
por: Guo, Ying, et al.
Publicado: (2022)

Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients
por: Einbinder, Yael, et al.
Publicado: (2022)

Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/Wyeth(TM))
por: da Silva, Mauro César, et al.
Publicado: (2023)

Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response
por: Cerbino-Neto, José, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome
por: Fiore, Vito, et al.
Publicado: (2021)

The SARS-CoV-2 vaccination rate and hesitation in Shanghai older adults with dementia
por: Yang, Yang, et al.
Publicado: (2023)

SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
por: Wei, Jia, et al.
Publicado: (2020)

Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
por: Schimpf, Judith, et al.
Publicado: (2022)

Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study
por: Pascucci, Domenico, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in the immunocompromised host
por: Connolly, Caoilfhionn M., et al.
Publicado: (2022)

The fourth vaccination with a non-SARS-CoV-2 variant adapted vaccine fails to increase the breadth of the humoral immune response
por: Hein, Sascha, et al.
Publicado: (2023)

Evolution of community health workers: the fourth stage
por: Mor, Nachiket, et al.
Publicado: (2023)

Humoral response after a third and fourth dose of mRNA-based SARS-CoV-2 vaccine in previously seronegative kidney transplant recipients
por: Brandstetter, Clara, et al.
Publicado: (2022)

The relationship between acquaintance with a SARS-CoV-2 death, positive SARS-CoV-2 test results, and sleep duration among college students in fall 2020
por: Garcia Colato, Edlin, et al.
Publicado: (2022)

Fostering Flu Vaccination in Healthcare Workers: Forum Theatre in a University Hospital
por: Corsaro, Alice, et al.
Publicado: (2017)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
por: Nascimento Junior, José Adão Carvalho, et al.
Publicado: (2020)

An extraordinary wave of SARS-CoV2, the youngest and the least serious
por: Justribó, Elena, et al.
Publicado: (2023)

Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective
por: Vaid, Ashok, et al.
Publicado: (2023)

Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
por: Zhao, Ting, et al.
Publicado: (2022)

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
por: Zou, Yuntao, et al.
Publicado: (2022)

Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications
por: Orendáčová, Mária, et al.
Publicado: (2022)

Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, Switzerland
por: Santa-Ramírez, Hugo-Alejandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3j8iujv6s8lfhonjueje31v46j